InChI=1S/C25H40N2O6S/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 16- 22(21(28) 15- 14- 17- 23(29) 30) 34- 19- 20(26) 25(33) 27- 18- 24(31) 32/h6- 7,9- 13,16,20- 22,28H,2- 5,8,14- 15,17- 19,26H2,1H3,(H,27,33) (H,29,30) (H,31,32) /b7- 6- ,10- 9- ,12- 11+,16- 13+/t20- ,21- ,22+/m0/s1 |
YEESKJGWJFYOOK-IJHYULJSSA-N |
CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
bronchoconstrictor agent
A drug which causes a narrowing of the lumen of a bronchus or bronchiole.
|
|
View more via ChEBI Ontology
S- {(1R,2E,4E,6Z,9Z)- 1- [(1S)- 4- carboxy- 1- hydroxybutyl]pentadeca- 2,4,6,9- tetraen- 1- yl}- L- cysteinylglycine
|
(R- (R*,S*- (E,E,Z,Z)))- N- (S- (1- (4- Carboxy- 1- hydroxybutyl)- 2,4,6,9- pentadecatetraenyl)- L- cysteinyl)glycine
|
ChemIDplus
|
5S-hydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11E,14Z-eicosatetraenoic acid
|
LIPID MAPS
|
Leukotriene D4
|
KEGG COMPOUND
|
LTD4
|
KEGG COMPOUND
|
4726738
|
Reaxys Registry Number
|
Reaxys
|
73836-78-9
|
CAS Registry Number
|
ChemIDplus
|
23825762
|
PubMed citation
|
Europe PMC
|
9160411
|
PubMed citation
|
Europe PMC
|
|